For instance, GALNT3 was proposed as a marker of non-small cell lung cancer prognosis [28], whereas GALNT6 and GALNT14 itself were proposed as potential tissue biomarkers, since their high expression in breast and gastric carcinomas [29–32]. This evidence concerns the gene GALNT3 and non-small cell lung carcinoma.